ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,475.09
      0.27%
      US Tech 100
      19,192.00
      -0.44%
      Dow Jones
      39,169.52
      0.13%
      Brent Oil
      86.835
      0.35%
      Bitcoin
      62,615.36
      -0.37%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Gossamer Bio Inc (GOSS)

      7. Gossamer Bio Inc (GOSS) News

      GOSS

      Gossamer Bio (GOSS)

      Gossamer Bio Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:GOSS
      DateTimeSourceHeadlineSymbolCompany
      11/22/20237:07PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GOSSGossamer Bio Inc
      11/22/20237:07PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GOSSGossamer Bio Inc
      11/17/20234:01PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GOSSGossamer Bio Inc
      11/14/20236:24PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GOSSGossamer Bio Inc
      11/09/20237:31AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:GOSSGossamer Bio Inc
      11/09/20237:31AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:GOSSGossamer Bio Inc
      11/09/20237:31AMBusiness WireGossamer Bio Announces Third Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:GOSSGossamer Bio Inc
      10/20/20234:01PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:GOSSGossamer Bio Inc
      10/03/20234:08PMBusiness WireGossamer Bio Announces Addition of Rainer Zimmermann, MD, as VP of Medical AffairsNASDAQ:GOSSGossamer Bio Inc
      09/07/20235:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:GOSSGossamer Bio Inc
      09/07/20237:44AMBusiness WireGossamer Bio to Present Results of TORREY FRI Sub-Study at the European Respiratory Society International Congress 2023NASDAQ:GOSSGossamer Bio Inc
      08/29/202312:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:GOSSGossamer Bio Inc
      08/28/20234:29PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:GOSSGossamer Bio Inc
      08/21/20234:01PMEdgar (US Regulatory)Form DEL AM - Delaying amendmentNASDAQ:GOSSGossamer Bio Inc
      08/18/20238:41AMEdgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:GOSSGossamer Bio Inc
      08/18/20238:38AMEdgar (US Regulatory)Form RW - Registration Withdrawal RequestNASDAQ:GOSSGossamer Bio Inc
      08/17/20234:01PMEdgar (US Regulatory)Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuersNASDAQ:GOSSGossamer Bio Inc
      08/08/20234:03PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:GOSSGossamer Bio Inc
      08/08/20234:01PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:GOSSGossamer Bio Inc
      08/08/20234:01PMBusiness WireGossamer Bio Announces Second Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:GOSSGossamer Bio Inc
      08/07/20234:44PMEdgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:GOSSGossamer Bio Inc
      07/28/20233:46PMEdgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipNASDAQ:GOSSGossamer Bio Inc
      07/26/20234:03PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GOSSGossamer Bio Inc
      07/24/20234:16PMBusiness WireGossamer Bio to Hold Conference Call with PAH Experts to Discuss PROSERA Phase 3 Design and Interim TORREY OLE ResultsNASDAQ:GOSSGossamer Bio Inc
      07/20/20234:01PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:GOSSGossamer Bio Inc
      07/20/20237:56AMBusiness WireGossamer Bio Announces $212 Million Private Placement FinancingNASDAQ:GOSSGossamer Bio Inc
      07/20/20237:50AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:GOSSGossamer Bio Inc
      06/26/20234:02PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GOSSGossamer Bio Inc
      06/09/20234:16PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GOSSGossamer Bio Inc
      06/09/20234:16PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GOSSGossamer Bio Inc
       Showing the most relevant articles for your search:NASDAQ:GOSS